The Journal of Experimental Medicine · 1996 · 63 citations · 24 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyImmunoregulationAutoimmune Disease PathogenesisAutoimmune DiseasesCostimulatory SignalingHelper T Cell SubsetsRegulation Of AutoimmunityT Cell BiologyAutoimmune Immune Complex DiseaseCd40l SignalingImmune Complex Disease PathogenesisMercury-induced ImmunotoxicityRenal Immune Complex DiseaseT Cell Costimulatory PathwaysT Helper CellsTh2 Immune Response
We assessed the role of CD40-CD40L, cytotoxic T lymphocyte (CTL)A4/CD28-B7s, and CD2-CD48/CD58 lymphocyte costimulatory pathways in the development of mercury chloride (HgCl2)-induced autoimmune disease in mice, which is believed to be mediated by T helper (Th) subset Th2. Inhibition of CD40-CD40-L and CTLA4/CD28-B7s interactions by anti-CD40-L antibody and soluble CTLA4-immunoglobulin (Ig) fusion protein, respectively, abrogated the autoimmune disease without affecting interleukin 4 (IL-4) production, showing the importance of physical contact between T and B lymphocytes in the Th2-mediated process. In contrast, two anti-CD2 antibodies that have been shown to induce immunosuppression of Th1-mediated events exacerbated the autoantibody response and augmented IgG1, IgE, and IL-4 production, transforming a mild mesangial glomerulopathy into a severe systemic immune complex disease. These observations demonstrate that manipulation of lymphocyte accessory counterreceptor interactions may affect the course of Th2-associated autoimmune disease and suggest that signals resulting from CD2 engagement play an essential role in the regulation of the Th1-Th2 effector equilibrium.
24
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Peter S. Linsley, Philip M. Wallace, Jennifer Johnson et al. · Science · 1992 · 806 citations